We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Innovative DNA Technology May Provide More Efficient Disease Detection and Treatment

By LabMedica International staff writers
Posted on 17 Feb 2016
Print article
Researchers have developed a novel DNA aptamer with potential to improve detection and targeted treatment of infectious diseases and other illnesses, such as cancer.

The new aptamer was developed by researchers at the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR (Agency for Science, Technology and Research; Singapore) by improving on existing technologies for synthesizing aptamers, modified single-stranded DNA molecules. DNA aptamers can specifically bind to molecular targets in the body such as proteins, viruses, bacteria, and cells. DNA aptamers are made for a given target to bind and inhibit its activity, giving this technology potential for disease detection and drug delivery. But no DNA aptamers have been approved for clinical use because current aptamers do not bind well to targets and are easily digested by enzymes.

“To overcome these challenges, we have created a DNA aptamer with strong binding ability and stability with superior efficacy. We hope to use our DNA aptamers as the platform technology for diagnostics and new drug development,” said IBN Executive Director Prof. Jackie Y. Ying.

The research team was led by principal research scientist and team leader Dr. Ichiro Hirao. To tackle the weak target-binding problem, they added a new artificial component, an “unnatural base,” to a standard DNA aptamer, which typically has 4 components. The addition of the 5th component greatly enhanced the binding ability to the molecular target by 100 times compared to conventional DNA aptamers. Furthermore, to prevent the aptamer from being quickly digested by enzymes, a unique “mini-hairpin DNA” was added.

Dr. Hirao explained: “The mini-hairpin DNAs have an unusually stable and compact stem-loop structure, like a hairpin, of small DNA fragments. Their structure strongly resists the digestive enzymes, so I added them to specific positions on the DNA aptamer to act as a protective shield. Usually DNAs are digested within one hour in blood at body temperature. With the mini-hairpin DNA, our DNA aptamers can survive for days instead of hours. This is important for pharmaceutical applications, which require the therapeutic to remain in the body for a longer period.”

DNA aptamers could replace or complement the existing use of antibodies in drugs for targeted disease treatment. Antibodies often cause undesirable immune response and are not easy to mass produce with high quality.

“We can now generate very promising DNA aptamers for clinical use. Our aptamers are more efficient, and lower in cost and toxicity compared to conventional methods. The next step of our research is to use the aptamers to detect and deactivate target molecules and cells that cause infectious diseases, such as dengue, malaria, and Methicillin-resistant Staphylococcus aureus (MRSA), as well as cancer,” added Dr Hirao.

The study, by Matsunaga K et al, was published December 22, 2015, in the journal Scientific Reports.

Related Links:

Institute of Bioengineering and Nanotechnology at A*STAR


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.